Xindi Chen

Ms. Xindi Chen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
TGTeri Greiling
Teri Greiling
CDCarina Dehner
Carina Dehner
XCXinguo Chen
Xinguo Chen
KHKevin Hughes
Kevin Hughes
AIAlonso J. Iñiguez
Alonso J. Iñiguez
MKMartin A. Kriegel
Martin A. Kriegel
Commensal bacterial orthologs of the human autoantigen Ro60 may trigger cross-reactive T and B cells that initiate and sustain chronic autoimmunity in lupus.

31 August 2017 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
JPJoel Pekow
Joel Pekow
KMKatherine Meckel
Katherine Meckel
UDUrszula Dougherty
Urszula Dougherty
YHYong Huang
Yong Huang
XCXindi Chen
Xindi Chen
MBMarc Bissonnette
Marc Bissonnette
Purpose: Patients with ulcerative colitis are at increased risk for colorectal cancer, although mechanisms underlying neoplastic transformation are poorly understood. We sought to evaluate the role of microRNAs in neoplasia development in this high-risk population. Experimental Design: Tissue from 12 controls, 9 ulcerative colitis patients without neoplasia, and 11 ulcerative colitis patients with neoplasia was analyzed. miRNA array analysis was performed and select miRNAs assayed by real-time PCR on the discovery cohort and a validation cohort. DNA methylation of miR-193a was assessed. Following transfection of miR-193a-3p, proliferation, IL17RD expression, and luciferase activity of the 3′UTR of IL17RD were measured. Tumor growth in xenografts as well as EGFR signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3′ untranslated region (UTR) or wild-type (WT) 3′UTR. Results: miR-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue. Significant down-regulation of miR-193a-3p was also seen in an independent cohort of ulcerative colitis cancers. Changes in methylation of miR-193a or expression of pri-miR-193a were not observed in ulcerative colitis cancer. Transfection of miR-193a-3p resulted in decreased proliferation, and identified IL17RD as a direct target of miR-193a-3p. IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3′UTR compared with cells expressing IL17RD with mutant 3′UTR. Conclusions: miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD. These findings provide novel insight into inflammation-driven colorectal cancer and could suggest new therapeutic targets in this high-risk population. Clin Cancer Res; 23(17); 5281–91. ©2017 AACR.

1 July 2016 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
KMKatherine Meckel
Katherine Meckel
YLYan Chun Li
Yan Chun Li
JLJohn Lim
John Lim
MKMasha Kocherginsky
Masha Kocherginsky
CWChris Weber
Chris Weber
JPJoel Pekow
Joel Pekow
Background: Vitamin D exerts anti-inflammatory actions both in vitro and in murine models of colitis. In previous studies, we demonstrated that vitami

1 February 2015 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
JPJoel Pekow
Joel Pekow
KMKatherine Meckel
Katherine Meckel
UDUrszula Dougherty
Urszula Dougherty
FBFatma Butun
Fatma Butun
RMReba Mustafi
Reba Mustafi
MBMarc Bissonnette
Marc Bissonnette
The colon differs regionally in local luminal environment, excretory function, and gene expression. Polycistronic microRNA (miR)-143 and miR-145 are downregulated early in colon cancer. We asked if these microRNAs (miRNAs) might be differentially expressed in the proximal vs. the distal colon, contributing to regional differences in protein expression. Primary transcripts and mature miR-143 and miR-145 were quantified by real-time PCR, putative targets were measured by Western blotting, and DNA methylation was assessed by sequencing bisulfite-treated DNA in proximal and distal normal colonic mucosa as well as colon cancers. Putative targets of these miRNAs were assessed following transfection with miR-143 or miR-145. Mean expression of mature miR-143 and miR-145 was 2.0-fold (P < 0.001) and 1.8-fold (P = 0.03) higher, respectively, in proximal than distal colon. DNA methylation or primary transcript expression of these miRNAs did not differ by location. In agreement with increased expression of miR-143 and miR-145 in proximal colon, predicted targets of these miRNAs, apoptosis inhibitor 5 (API5), ERK5, K-RAS, and insulin receptor substrate 1 (IRS-1), which are cell cycle and survival regulators, were expressed at a lower level in proximal than distal colon. Transfection of HCA-7 colon cancer cells with miR-145 downregulated IRS-1, and transfection of HT-29 colon cancer cells with miR-143 decreased K-RAS and ERK5 expression. In conclusion, miR-143 and miR-145 and the predicted target proteins API5, ERK5, K-RAS, and IRS-1 display regional differences in expression in the colon. We speculate that differences in these tumor suppressors might contribute to regional differences in normal colonic gene expression and modulate site-specific differences in malignant predisposition.

8 October 2022 in Clinical Imaging
Verified
Journal Article
Closed access
DNDerek L. Nguyen
Derek L. Nguyen
XCXindi Chen
Xindi Chen
LKLily Kwak
Lily Kwak
EOEniola T. Oluyemi
Eniola T. Oluyemi
LMLisa A. Mullen
Lisa A. Mullen
EAEmily B. Ambinder
Emily B. Ambinder

5 September 2025 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
XCXindi Chen
Xindi Chen
LALouay Almidani
Louay Almidani
SBSeema Banerjee
Seema Banerjee
JTJonathan Thomas
Jonathan Thomas
AMAleksandra Mihailovic
Aleksandra Mihailovic
PRPradeep Ramulu
Pradeep Ramulu